Healthcare

Moleculin Biotech Inc., a micro-cap clinical-stage biopharmaceutical company developing treatments for difficult-to-treat cancers, declined on June 23, 2026, as a broad macro risk-off session weighed heavily on speculative small-cap growth categories.

KALA Bio Inc., a clinical-stage biopharmaceutical company developing treatments for serious ophthalmic diseases, fell 11.86% on June 23, 2026, as a broad macro risk-off event extended selling pressure across small-cap clinical-stage biotechs with no near-term revenue.

As of the latest available intraday update, MRNA shares rose 4.57% to $62.06. The positive move extended a strong recent run following a unanimous endorsement from FDA advisers on June 18.

Wellgistics Health, Inc. (NASDAQ:WGRX) traded near $3.13 during today’s session, gaining approximately $0.03 from its previous close of $3.10.

Trulieve Cannabis Corp. (NYSE:TRLV) traded near $8.53 during today’s trading session, falling $0.59 from its previous close of $9.12. The stock opened at $9.05 and moved between $8.25 and $9.05 as selling accelerated after the start of regular trading.

SL Science Holding Limited (NASDAQ:SLBT) traded near $3.95 during today’s session, falling $0.57 from its previous close of $4.52. The shares opened at $4.09 and moved between $3.84 and $4.24 before remaining close to the lower end of the range.

Regencell Bioscience Holdings Limited (NASDAQ:RGC) traded near $11.37 during today’s session, rising $0.86 from its previous close of $10.51. The stock opened at $10.67 and moved between $10.48 and $12 before retaining most of its advance.